Back to ANRO
GOLDMAN SACHS GROUP INC → ANRO
GOLDMAN SACHS GROUP INC ANRO Position History
Alto Neuroscience, Inc. • Healthcare
Quarters held
14
Latest value
$3M
Q3 2026
Peak value
$7.3M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $323K |
| Q2 2025 | $42K |
| Q3 2025 | $270K |
| Q3 2025 | $93K |
| Q4 2025 | $228K |
| Q4 2025 | $2.6M |
| Q4 2025 | $2.6M |
| Q4 2025 | $228K |
| Q1 2026 | $2.1M |
| Q1 2026 | $240K |
| Q2 2026 | $5.1M |
| Q2 2026 | $1.2M |
| Q3 2026 | $7.3M |
| Q3 2026 | $3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3M | 118.8K | — | — |
| Q3 2026 | $7.3M | 285.9K | — | — |
| Q2 2026 | $1.2M | 43.8K | — | — |
| Q2 2026 | $5.1M | 193.0K | — | — |
| Q1 2026 | $240K | 10.7K | — | — |
| Q1 2026 | $2.1M | 94.0K | — | — |
| Q4 2025 | $228K | 12.8K | — | — |
| Q4 2025 | $2.6M | 143.5K | — | — |
| Q4 2025 | $2.6M | 143.5K | — | — |
| Q4 2025 | $228K | 12.8K | — | — |
| Q3 2025 | $93K | 23.0K | — | — |
| Q3 2025 | $270K | 67.2K | — | — |
| Q2 2025 | $42K | 19.1K | — | — |
| Q2 2025 | $323K | 147.0K | — | — |
Other funds holding ANRO
$97.8M
$94.7M
$83.4M
$71.9M
$69.5M
$61.2M